2025-04-08 18:35:12
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Lincoln Pharmaceuticals Q4FY22 consolidated PAT falls to Rs. 11.02 crores
Posted On : 2022-05-19 13:01:18( TIMEZONE : IST )
Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 104.4777 crores during the period ended March 31, 2022 as compared to Rs. 122.5157 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 11.0241 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 17.6018 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 5.50 for the period ended March 31, 2022 as compared to Rs. 8.79 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 104.4777 crs | ₹122.5157 crs |  -14.72% |
| Net Profit | ₹11.0241 crs | ₹17.6018 crs | -37.37% |
| EPS | ₹5.50 | ₹8.79 | -37.43% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 104.4777 crores during the period ended March 31, 2022 as compared to Rs.82.1153 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.11.0241 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.12.5834 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.5.50 for the period ended March 31, 2022 as compared to Rs.6.28 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 104.4777 crs | ₹82.1153 crs |  27.23% |
| Net Profit | ₹11.0241 crs | ₹12.5834 crs | -12.39% |
| EPS | ₹5.50 | ₹6.28 | -12.42% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.482.1210 crores during the Financial Year ended March 31, 2022 as compared to Rs.429.8493 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.69.3552 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.62.2502 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.34.63 for the Financial Year ended March 31, 2022 as compared to Rs.31.08 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹482.1210 crs | ₹429.8493 crs | 12.16% |
| Net Profit | ₹69.3552 crs | ₹62.2502 crs | 11.41% |
| EPS | ₹34.63 | ₹31.08 | 11.42% |
Shares of Lincoln Pharmaceuticals Limited was last trading in BSE at Rs. 308.00 as compared to the previous close of Rs. 310.80. The total number of shares traded during the day was 3253 in over 230 trades.
The stock hit an intraday high of Rs. 314.65 and intraday low of 305.00. The net turnover during the day was Rs. 1005438.00.
